Psychotherapy for depression among advanced, incurable cancer patients: A systematic review and meta-analysis

Cancer Treatment Reviews

Volumn 56, Issue , 2017, Pages 16-27

  Okuyama, Toru ^a,b   Akechi, Tatsuo ^a,b   Mackenzie, Lisa ^c,d   Furukawa, Toshi A ^e  

^a NAGOYA CITY UNIVERSITY HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anxiety; Depression; Neoplasms; Palliative care; Psycho oncology; Psychotherapy

Indexed keywords

ADVANCED CANCER; ANXIETY; CANCER PATIENT; COGNITIVE THERAPY; DEPRESSION; DISTRESS SYNDROME; HUMAN; HYPNOSIS; INDIVIDUAL MEANING CENTERED PSYCHOTHERAPY; MASSAGE; MEANING MAKING INTERVENTION; META ANALYSIS; PSYCHOEDUCATION; PSYCHOTHERAPY; QUALITY OF LIFE; RELAXATION TRAINING; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; DEPRESSIVE DISORDER; NEOPLASMS; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DEPRESSION; DEPRESSIVE DISORDER; HUMANS; NEOPLASMS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85018651210     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2017.03.012     Document Type: Review

References (57)

1. [1] Mitchell, A.J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 12 (2011), 160–174.
2. [2] Block, S.D., Assessing and managing depression in the terminally ill patient. ACP-ASIM end-of-life care consensus panel. American College of Physicians – American Society of Internal Medicine. Ann Int Med 132 (2000), 209–218.
3. [3] Higginson, I.J., Costantini, M., Dying with cancer, living well with advanced cancer. Eur J Cancer 44 (2008), 1414–1424.
4. [4] Mathes, T., Pieper, D., Antoine, S.L., Eikermann, M., Adherence influencing factors in patients taking oral anticancer agents: a systematic review. Cancer Epidemiol 38 (2014), 214–226.
5. [5] Henriksson, M.M., Isometsa, E.T., Hietanen, P.S., Aro, H.M., Lonnqvist, J.K., Mental disorders in cancer suicides. J Affect Disord 36 (1995), 11–20.
6. [6] Rhondali, W., Chirac, A., Laurent, A., Terra, J.L., Filbet, M., Family caregivers' perceptions of depression in patients with advanced cancer: a qualitative study. Palliat Support Care 13 (2014), 1–8.
7. [7] Prieto, J.M., Blanch, J., Atala, J., Carreras, E., Rovira, M., Cirera, E., et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol 20 (2002), 1907–1917.
8. [8] Pinquart, M., Duberstein, P.R., Depression and cancer mortality: a meta-analysis. Psychol Med 40 (2010), 1797–1810.
9. [9] Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., Hotopf, M., Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev, 6, 2015.
10. [10] Lloyd-Williams, M., Payne, S., Reeve, J., Dona, R. Kolamunnage, Antidepressant medication in patients with advanced cancer – an observational study. QJM 106 (2013), 995–1001.
11. [11] Okamura, M., Akizuki, N., Nakano, T., Shimizu, K., Ito, T., Akechi, T., et al. Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. Psychooncology 17 (2008), 154–160.
12. [12] Okuyama, T., Nakane, Y., Endo, C., Seto, T., Kato, M., Seki, N., et al. Mental health literacy in Japanese cancer patients: ability to recognize depression and preferences of treatments-comparison with Japanese lay public. Psychooncology 16 (2007), 834–842.
13. [13] McHugh, R.K., Whitton, S.W., Peckham, A.D., Welge, J.A., Otto, M.W., Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiat 74 (2013), 595–602.
14. [14] Corsini, R.J., Introduction. Corsini, R.J.W.D., (eds.) Current psychotherapies, 2000, F.E. Peacock Publishers, Inc., Itasca Illinois, 1–4.
15. [15] O'Donovan, A., Casey, L., van der Veen, M., Boschen, M., Psychotherapy: an Australian perspective. 2013, IP Communications, Hawthorn (Victoria, Australia).
16. [16] Wheeler, K., The nurse psychotherapists and a framework for practice. Wheeler, K., (eds.) Psychotherapy for the advanced practice psychiatric nurse: a how to guide for evidence-based practice, 2014, Springer Publishing Company, New York, 3–6.
17. [17] Faller, H., Schuler, M., Richard, M., Heckl, U., Weis, J., Kuffner, R., Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol 31 (2013), 782–793.
18. [18] Hart, S.L., Hoyt, M.A., Diefenbach, M., Anderson, D.R., Kilbourn, K.M., Craft, L.L., et al. Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst 104 (2012), 990–1004.
19. [19] Akechi, T., Okuyama, T., Onishi, J., Morita, T., Furukawa, T.A., Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev, 2, 2008.
20. [20] Thase, M.T., Psychotherapy of mood disorders. Gabbard, G.O., (eds.) Gabbard's treatments of psychiatric disorders, 2014, American Psychiatric Publishing, Washington (DC), 221–248.
21. [21] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group P, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Int Med, 151(264–9), 2009, W64.
22. [22] Lepper, G., A pragmatic approach to the study of therapeutic interaction: toward an observational science of psychotherapy process. Gelo, O.C.G., Pritz, A., Rieken, B., (eds.) Psychotherapy research, 2015, Springer, Vienna, 517–534.
23. [23] Madill, A., Conversation analysis and psychotherapy process research. Gelo, O.C.G., Pritz, A., Rieken, B., (eds.) Psychotherapy research, 2015, Springer, Vienna, 501–515.
24. [24] Department of Health. Talking therapies: a four-year plan of action. < http://wwwiaptnhsuk/silo/files/talking-therapies-a-four-year-plan-of-actionpdf2011>.
25. [25] Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., An inventory for measuring depression. Arch Gen Psychiat 4 (1961), 561–571.
26. [26] McNair, D.M., Lorr, M., Droppleman, L.F., Edits manual for the profile of mood states. 1992, Edits/Educational and Industrial Testing Service, San Diego.
27. [27] Association. AP. Diagnostic and statistical manual of mental disorders (DSM-IV), 4th ed. Washington: American Psychiatric Press; 1994.
28. [28] Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.
29. [29] Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011.
30. [30] Furukawa, T.A., From effect size into number needed to treat. Lancet, 353, 1999, 1680.
31. [31] Savović, J., Jones, H., Altman, D., Harris, R., Jűni, P., Pildal, J., et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technol Assess 16 (2012), 1–82.
32. [32] Schünemann H, Brożek J, Guyatt G, Oxman A. GRADE handbook. In: Group TGW, editor; 2013.
33. [33] Classen, C., Butler, L.D., Koopman, C., Miller, E., DiMiceli, S., Giese-Davis, J., et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiat 58 (2001), 494–501.
34. [34] Edelman, S., Bell, D.R., Kidman, A.D., A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psychooncology 8 (1999), 295–305.
35. [35] Goodwin, P.J., Leszcz, M., Ennis, M., Koopmans, J., Vincent, L., Guther, H., et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345 (2001), 1719–1726.
36. [36] Linn, M.W., Linn, B.S., Harris, R., Effects of counseling for late stage cancer patients. Cancer 49 (1982), 1048–1055.
37. [37] Spiegel, D., Bloom, J.R., Yalom, I., Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiat 38 (1981), 527–533.
38. [38] Wood, B.C., Mynors-Wallis, L.M., Problem-solving therapy in palliative care. Palliat Med 11 (1997), 49–54.
39. [39] Laidlaw, T., Bennett, B.M., Dwivedi, P., Naito, A., Gruzelier, J., Quality of life and mood changes in metastatic breast cancer after training in self-hypnosis or Johrei: a short report. Contemp Hypn 22 (2005), 84–93.
40. [40] Liossi, C., White, P., Efficacy of clinical hypnosis in the enhancement of quality of life of terminally ill cancer patients. Contemp Hypn 18 (2001), 145–160.
41. [41] Sloman, R., Relaxation and imagery for anxiety and depression control in community patients with advanced cancer. Cancer Nurs 25 (2002), 432–435.
42. [42] Wu, L., Wang, S., Psychotherapy improving depression and anxiety of patients treated with chemotherapy combined with radiotherapy. Chin J Clin Rehabil 7 (2003), 2462–2463.
43. [43] Ando, M., Morita, T., Akechi, T., Okamoto, T., Efficacy of short-term life-review interviews on the spiritual well-being of terminally ill cancer patients. J Pain Symptom Manage 39 (2010), 993–1002.
44. [44] Breitbart, W., Poppito, S., Rosenfeld, B., Vickers, A.J., Li, Y., Abbey, J., et al. Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer. J Clin Oncol 30 (2012), 1304–1309.
45. [45] Greer, J.A., Traeger, L., Bemis, H., Solis, J., Hendriksen, E.S., Park, E.R., et al. A pilot randomized controlled trial of brief cognitive-behavioral therapy for anxiety in patients with terminal cancer. Oncologist 17 (2012), 1337–1345.
46. [46] Henry, M., Cohen, S.R., Lee, V., Sauthier, P., Provencher, D., Drouin, P., et al. The meaning-making intervention (MMi) appears to increase meaning in life in advanced ovarian cancer: a randomized controlled pilot study. Psychooncology 19 (2010), 1340–1347.
47. [47] Kissane, D.W., Grabsch, B., Clarke, D.M., Smith, G.C., Love, A.W., Bloch, S., et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 16 (2007), 277–286.
48. [48] Rost, A.D., Wilson, K.G., Buchanan, E., Hildebrandt, M.J., Mutch, D., Improving psychological adjustment among late-stage ovarian cancer patients: examining the role of avoidance in treatment. Cogn Behav Pract 19 (2012), 508–517.
49. [49] Savard, J., Simard, S., Giguere, I., Ivers, H., Morin, C.M., Maunsell, E., et al. Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat Support Care 4 (2006), 219–237.
50. [50] Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983), 361–370.
51. [51] Rayner, L., Price, A., Hotopf, M., Higginson, I.J., The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer 47 (2011), 702–712.
52. [52] Uitterhoeve, R.J., Vernooy, M., Litjens, M., Potting, K., Bensing, J., De Mulder, P., et al. Psychosocial interventions for patients with advanced cancer – a systematic review of the literature. Br J Cancer 91 (2004), 1050–1062.
53. [53] Penrod, J.D., Morrison, R.S., Challenges for palliative care research. J Palliat Med 7 (2004), 398–402.
54. [54] Manne, S., Andrykowski, M., Are psychological interventions effective and accepted by cancer patients? II. Using empirically supported therapy guidelines to decide. Ann Behav Med 32 (2006), 98–103.
55. [55] Lilienheld, S.O., Psychological treatments that cause harm. Perspect Psychol Sci 2 (2007), 53–70.
56. [56] Linden, M., How to define, find and classify side effects in psychotherapy: from unwanted events to adverse treatment reactions. Clin Psychol Psychother 20 (2013), 286–296.
57. [57] Jonsson, U., Alaie, I., Parling, T., Arnberg, F.K., Reporting of harms in randomized controlled trials of psychological interventions for mental and behavioral disorders: a review of current practice. Contemp Clin Trials 38 (2014), 1–8.